HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ousmane M Diop Selected Research

acute flaccid myelitis

6/2022Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
5/2020Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2018-2019.
4/2019Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2017-2018.
4/2018Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2016-2017.
1/2018Population sensitivity of acute flaccid paralysis and environmental surveillance for serotype 1 poliovirus in Pakistan: an observational study.
1/2018Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.
4/2017Surveillance Systems to Track Progress Toward Polio Eradication - Worldwide, 2015-2016.
11/2016Satellite imagery technology in public health: analysis of site catchment areas for assessment of poliovirus circulation in Nigeria and Niger.
4/2015Tracking progress toward polio eradication - worldwide, 2013-2014.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ousmane M Diop Research Topics

Disease

22Poliomyelitis (Polio)
06/2022 - 04/2013
9acute flaccid myelitis
06/2022 - 04/2015
6Infections
07/2020 - 01/2004
5Paralysis (Palsy)
04/2022 - 06/2015
3Human Influenza (Influenza)
11/2020 - 02/2013
2Acquired Immunodeficiency Syndrome (AIDS)
06/2008 - 04/2006
1Bruton type agammaglobulinemia
01/2020
1Measles
01/2015
1Inflammation (Inflammations)
06/2006
1Carcinoma (Carcinomatosis)
07/2004
1Neoplasms (Cancer)
07/2004
1Prostatic Neoplasms (Prostate Cancer)
07/2004

Drug/Important Bio-Agent (IBA)

26VaccinesIBA
06/2022 - 07/2004
10Oral Poliovirus Vaccine (Sabin Vaccine)IBA
04/2022 - 04/2013
2AntibodiesIBA
01/2018 - 07/2004
2WastewaterIBA
01/2018 - 11/2016
2Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2006 - 04/2005
2Interleukin-10 (Interleukin 10)IBA
06/2006 - 04/2005
1Antiviral Agents (Antivirals)IBA
07/2020
1Nucleic AcidsIBA
01/2018
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1Viral ProteinsIBA
01/2018
1Viral VaccinesIBA
01/2017
1Immunoglobulin M (IgM)IBA
01/2015
1Pharmaceutical PreparationsIBA
02/2013
1Oseltamivir (Tamiflu)FDA Link
02/2013
1Neuraminidase (Sialidase)IBA
02/2013
1Interferon-alpha (Interferon Alfa)IBA
06/2008
1CytokinesIBA
06/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2006
1Transforming Growth Factor beta (TGF-beta)IBA
04/2005
1GlycopeptidesIBA
07/2004
1AntigensIBA
07/2004
1GlycoconjugatesIBA
07/2004
1Tn antigenIBA
07/2004
1keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
07/2004
1CarbohydratesIBA
07/2004
1Immunoglobulin G (IgG)IBA
07/2004
1DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
01/2004